It was showed a decrease on TEARLAB CORP (OTCMKTS:TEAR)’s short interest with 3.62%. FINRA issued short interest of TEAR’s total 13,300 shares. That’s 3.62% down from 13,800 shares. Former TEAR’s position will need 0 days to recover. It has 131,500 average volume.
TEAR is touching $0.1038 during the last trading session, after increased 3.80%.Currently TearLab Corporation is after 0.00% change in last November 10, 2017. TEAR has 495 shares volume. TEAR underperformed the S&P500 by 15.62%.
TearLab Corporation operates as an in-vitro diagnostic firm in the United States.The firm is valued at $1.12 million. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease.Currently it has negative earnings. The company??s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.